Dr. Alexandra Kautzky-Willer, MD
Claim this profileMedizinische Universität Wien
Clinical Trials Alexandra Kautzky-Willer, MD is currently running
Retatrutide
for Obesity
The main purpose of this study is to determine if retatrutide can significantly lower the incidence of serious heart-related complications or prevent the worsening of kidney function. The trial will enroll adults with body mass index 27 kg/m\^2 or higher and Atherosclerotic Cardiovascular Disease and/or chronic kidney disease. The study will last for about 5 years. Participants will have up to 27 clinic visits with the study doctor.
Recruiting
1 award
Phase 3
2 criteria
Lepodisiran
for Cardiovascular Disease
This trial is testing lepodisiran, a medication given as an injection under the skin. It targets people with high levels of lipoprotein(a) who have cardiovascular disease or are at risk of heart attack or stroke. The medication works by lowering lipoprotein(a) levels to reduce the risk of these cardiovascular events.
Recruiting
1 award
Phase 3
More about Alexandra Kautzky-Willer, MD
Clinical Trial Related
1 year of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Alexandra Kautzky-Willer, MD has experience with
- Tirzepatide
- Placebo
- Dulaglutide
- Orforglipron
- Insulin Glargine
- Lepodisiran
Breakdown of trials Alexandra Kautzky-Willer, MD has run
Type 2 Diabetes
Diabetes
Cardiovascular Disease
Chronic Kidney Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Alexandra Kautzky-Willer, MD specialize in?
Alexandra Kautzky-Willer, MD focuses on Type 2 Diabetes and Diabetes. In particular, much of their work with Type 2 Diabetes has involved treating patients, or patients who are undergoing treatment.
Is Alexandra Kautzky-Willer, MD currently recruiting for clinical trials?
Yes, Alexandra Kautzky-Willer, MD is currently recruiting for 2 clinical trials in Vienna Wien. If you're interested in participating, you should apply.
Are there any treatments that Alexandra Kautzky-Willer, MD has studied deeply?
Yes, Alexandra Kautzky-Willer, MD has studied treatments such as Tirzepatide, Placebo, Dulaglutide.
What is the best way to schedule an appointment with Alexandra Kautzky-Willer, MD?
Apply for one of the trials that Alexandra Kautzky-Willer, MD is conducting.
What is the office address of Alexandra Kautzky-Willer, MD?
The office of Alexandra Kautzky-Willer, MD is located at: Medizinische Universität Wien, Vienna, Wien 1090 Austria. This is the address for their practice at the Medizinische Universität Wien.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.